Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 1129

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 7A
Chunk 1129
---
 firm due to our
status as an emerging growth company under the JOBS Act.

Changes
in Internal Control over Financial Reporting

During
the quarter ended December 31, 2024, there has been no change in our internal control over financial reporting that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting.

Item
9B. Other Information.

Not
applicable.

Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not
applicable.

23

PART
III

Item
10. Directors, Executive Officers and Corporate Governance.

Directors
and Executive Officers

Our
directors and executive officers are as follows:

    Name
     
    Age
     
    Title
  
    Lei
    Huang
     
    53
     
    Chief
    Executive Officer and Director
  
    You
    (“Patrick”) Sun
     
    37
     
    Chief
    Financial Officer
  
    Huifeng
    Chang
     
    59
     
    Director
  
    Jim
    Mao
     
    57
     
    Director
  
    Kevin
    Vassily
     
    58
     
    Director

Lei Huang, Chief Executive Officer and Director

Mr. Huang has served as our director and Chief Executive Officer
since its inception. Mr. Huang has also served as a member of the board of directors of US Tiger Securities, Inc. (“US Tiger”)
since December 2019 and previously served as a director of its parent company, UP Fintech Holding Limited (Nasdaq: TIGR), from November
2020 until June 2022. Since December 2021, Mr. Huang has served as the Chief Executive Officer and has been a member of the board
of directors of TradeUP Securities, Inc., a broker/dealer company.

He has also been a member of the board of directors of MDL and International
Corporation since December 2020. He served as the Chief Executive Officer and was a member of the board of directors of Fortune Rise Acquisition
Corporation (Nasdaq: FRLA), a special purpose acquisition company, since its incorporation in January 2021 until December 2022. Prior
to joining US Tiger, Mr. Huang was the Chief Executive Officer of Haitong Securities USA LLC and also served as Chief Compliance
Officer and Operation Manager of